Compare BIO & KEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | KEP |
|---|---|---|
| Founded | 1952 | 1961 |
| Country | United States | South Korea |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Electric Utilities: Central |
| Sector | Industrials | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 28.8B |
| IPO Year | N/A | 1996 |
| Metric | BIO | KEP |
|---|---|---|
| Price | $268.44 | $16.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $358.50 | N/A |
| AVG Volume (30 Days) | 249.7K | ★ 686.9K |
| Earning Date | 04-30-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.51 | $3.39 |
| Revenue Next Year | $3.17 | $2.32 |
| P/E Ratio | $9.72 | ★ $4.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $7.19 |
| 52 Week High | $343.12 | $23.41 |
| Indicator | BIO | KEP |
|---|---|---|
| Relative Strength Index (RSI) | 42.90 | 35.52 |
| Support Level | $266.71 | $16.09 |
| Resistance Level | $289.61 | $17.30 |
| Average True Range (ATR) | 7.77 | 0.60 |
| MACD | 0.40 | -0.20 |
| Stochastic Oscillator | 31.78 | 14.71 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.